5 research outputs found
Hybrid Titania–Zirconia Nanoparticles Coated Adsorbent for Highly Selective Capture of Nucleosides from Human Urine in Physiological Condition
Modified nucleosides are important
biomarkers of cancers. For their
analysis, boronate adsorbents were widely used to selectively capture
them from urine, but often suffered from serious secondary hydrophobic
interaction and harsh alkaline extraction condition. In this work,
the hybrid titania–zirconia nanoparticles coated on porous
silica spheres (TiO<sub>2</sub>–ZrO<sub>2</sub>/SiO<sub>2</sub>) were developed for the first time as a selective adsorbent for
nucleosides under neutral conditions based on specific recognition
of its Lewis acid sites to the cis-diol group. It was found here that
TiO<sub>2</sub>–ZrO<sub>2</sub> has higher binding constants
than pure TiO<sub>2</sub> or ZrO<sub>2</sub>, and a significant improvement
of binding efficiencies was obtained by decreasing calcination temperature
to 400 °C. Moreover, physiological pH of urine (pH 6–7)
was found optimal to adsorb nucleosides and resist other Lewis base
interferences. By self-assembly of TiO<sub>2</sub>–ZrO<sub>2</sub> nanoparticles on silica, unprecedentedly high binding capacity
(35 mg/g) for nucleosides was obtained due to high surface area (350
m<sup>2</sup>/g) and abundant Lewis acid sites on the surface. Due
to efficient reduction of secondary hydrophobic interaction on the
inorganic surface, cis-diol nucleosides could be captured from 500-fold
non-cis-diol interferences. In the real sample application, nine nucleosides
have been quantified with relative recoveries in 83%–126%,
and 42 ribosylated metabolites had been identified with only 100 μL
of urine at physiological pH. Among them, two nucleosides have never
been identified in most previous studies using boronate adsorbents
for capture
Fast Equilibrium Micro-Extraction from Biological Fluids with Biocompatible Core–Sheath Electrospun Nanofibers
Sample preparation methods with high
temporal resolution and matrix
resistance will benefit fast direct analysis of analytes in a complex
matrix, such as drug monitoring in biofluids. In this work, the core–sheath
biocompatible electrospun nanofiber was fabricated as a micro-solid
phase extraction material. With the polyÂ(<i>N</i>-isopropylacrylamide)
(PNIPAAm) as sheath polymer and polystyrene (PS) as core polymer,
the fiber membrane was highly hydrophilic and exhibited good antifouling
ability to proteins and cells. Its complete expansion in aqueous solution
and its nanoscale fiber (100–200 nm) structure offered high
mass transfer rate of analytes between liquid and solid phases. The
equilibration time of microextraction with this membrane was all shorter
than 2 min for eight drugs tested, and the linear ranges covered more
than 3 orders of magnitude for most of them. This membrane could be
applied to monitor free drugs in plasma and their protein binding
kinetics by equilibrium–microextraction with a 2 min temporal
resolution. The results showed that the core–sheath electrospun
nanofiber membrane would be a better alternative of solid phase material
for microextraction with good matrix-resistance ability and high temporal
resolution
In Vivo Fast Equilibrium Microextraction by Stable and Biocompatible Nanofiber Membrane Sandwiched in Microfluidic Device
In vivo analysis
poses higher requirements about the biocompatibility,
selectivity and speed of analytical method. In this study, an in vivo
fast equilibrium microextraction method was developed with a biocompatible
core–sheath electrospun nanofiber membrane sandwiched within
a microfluidic unit. The polystyrene/collagen core–sheath nanofiber
membrane was coaxially electrospun and strengthened with in situ glutaraldehyde
cross-linking. This membrane not only kept high mass transfer rate,
large extraction capacity and biomatrix resistance as our previously
proposed membrane (Anal. Chem. 2013, 85 (12), 5924–5932), but
also got much better mechanical strength and stability in water. The
microfluidic device was designed to sandwich the membrane, and the
blood in vivo can be introduced into it and get contact with the membrane
repetitively. With this membrane and device, a 2-min equilibrium in
vivo extraction method was established, validated in a simulated blood
circulation system, and was used to monitor the pharmacokinetic profiles
of desipramine in rabbits. The free and total concentration of desipramine
in vivo was monitored with 10-min interval almost without rabbit blood
consumed. The results met well with those of in vitro extraction,
and a correlation factor of 0.99 was obtained
Additive-Free Synthesis of In<sub>2</sub>O<sub>3</sub> Cubes Embedded into Graphene Sheets and Their Enhanced NO<sub>2</sub> Sensing Performance at Room Temperature
In
this report, we developed an additive-free synthesis of In<sub>2</sub>O<sub>3</sub> cubes embedded into graphene networks with InN nanowires
(InN-NWs) and graphene oxide (GO) as precursors by a facile one-step
microwave-assisted hydrothermal method. In absence of GO, the InN-NWs
maintained their chemical composition and original morphology upon
the same treatment. At varying mass ratios of InN-NWs and GO, the
different morphologies and distributions of In<sub>2</sub>O<sub>3</sub> could be obtained on graphene sheets. The uniform distribution,
which is usually considered favorable for enhanced sensing performance,
was observed in In<sub>2</sub>O<sub>3</sub> cubes/reduced graphene
oxide (rGO) composites. The room-temperature NO<sub>2</sub> sensing
properties of the In<sub>2</sub>O<sub>3</sub> cubes/rGO composites-based
sensor were systematically investigated. The results revealed that
the sensor exhibited a significant response to NO<sub>2</sub> gas
with a concentration lower to 1 ppm, and an excellent selectivity,
even though the concentrations of interferential gases were 1000 times
that of NO<sub>2</sub>. The enhanced NO<sub>2</sub> sensing performances
were attributed to the synergistic effect of uniformly distributed
In<sub>2</sub>O<sub>3</sub> cubes and graphene sheets in the unique
hybrid architectures without the interfering of extra additives
Detection of Glutathione <i>in Vitro</i> and in Cells by the Controlled Self-Assembly of Nanorings
Taking advantage of a reduction-controlled biocompatible
condensation
reaction and self-assembly, we have developed a new method for the
determination of glutathione (GSH) concentration <i>in vitro</i> and in HepG2 human liver cancer cells. Upon reduction by GSH under
physiological conditions (pH 7.4 in buffer), the small molecule <b>CBT-CysÂ(SEt)</b> condenses and self-assembles into nanorings,
increasing the UV absorbance at 380 nm (with significant linear correlation
in the 0–87 μM GSH range and a limit of detection of
1 μM). This method is also selective to GSH rather than cysteine
in biological samples. Through the use of added internal standards,
we successfully determined the concentration of GSH in HepG2 cells
to be 14.96 μM (2.99 fmol/cell). To better understand the mechanism
of nanoring self-assembly, the condensation product of <b>CBT-CysÂ(SEt)</b> formed using different concentrations of GSH and different reaction
times were characterized by transmission electron microscopy (TEM)